Neuronetics (STIM) Total Current Liabilities (2017 - 2026)
Neuronetics' (STIM) quarterly Total Current Liabilities came in at $28.3 million in Q1 2026, up 13.86% year-on-year from $24.8 million in Q1 2025, and down 7.33% on a QoQ basis from $30.5 million in Q4 2025.
Neuronetics (STIM) Total Current Liabilities (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Total Current Liabilities data on file, last reported at $28.3 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 13.86% year-over-year to $28.3 million in Q1 2026; TTM through Mar 2026 was $28.3 million, a 13.86% increase from a year earlier, with the FY2025 full-year figure at $30.5 million, down 2.38% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $28.3 million, down from $30.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for STIM reached as high as $33.2 million in Q4 2022 and fell as low as $13.2 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $22.8 million across 5 years, with a median of $24.8 million in 2025.
- On a YoY basis, Total Current Liabilities climbed as much as 111.42% in 2022 and fell as far as 47.41% in 2022.
- Year by year, Total Current Liabilities stood at $33.2 million in 2022, then plunged by 40.32% to $19.8 million in 2023, then jumped by 57.81% to $31.3 million in 2024, then slipped by 2.38% to $30.5 million in 2025, then retreated by 7.33% to $28.3 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $28.3 million in Q1 2026, $30.5 million in Q4 2025, and $28.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 28.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.29 Mn |
| Dec 31, 2025 | 30.52 Mn |
| Sep 30, 2025 | 28.94 Mn |
| Jun 30, 2025 | 27.80 Mn |
| Mar 31, 2025 | 24.84 Mn |
| Dec 31, 2024 | 31.27 Mn |
| Sep 30, 2024 | 16.90 Mn |
| Jun 30, 2024 | 29.26 Mn |
| Mar 31, 2024 | 14.50 Mn |
| Dec 31, 2023 | 19.81 Mn |
| Sep 30, 2023 | 15.34 Mn |
| Jun 30, 2023 | 15.03 Mn |
| Mar 31, 2023 | 15.13 Mn |
| Dec 31, 2022 | 33.20 Mn |
| Sep 30, 2022 | 25.14 Mn |
| Jun 30, 2022 | 18.94 Mn |
| Mar 31, 2022 | 13.18 Mn |
| Dec 31, 2021 | 15.70 Mn |
| Sep 30, 2021 | 47.81 Mn |
| Jun 30, 2021 | 11.58 Mn |